Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain

Research output: Contribution to journal › Editorial

Access to Document

@article{cbed30c83028423f80e4ee0ba937e14d,

title = "Semorinemab in Mild-to-Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain",

author = "Edland, {Steven D.} and Llibre-Guerra, {Jorge J.}",

year = "2023",

month = oct,

day = "3",

doi = "10.1212/WNL.0000000000207861",

language = "English",

volume = "101",

pages = "593--594",

journal = "Neurology",

issn = "0028-3878",

number = "14",

}

TY - JOUR

T1 - Semorinemab in Mild-to-Moderate Alzheimer Disease

T2 - A Glimmer of Hope Though Cautions Remain

AU - Edland, Steven D.

AU - Llibre-Guerra, Jorge J.

PY - 2023/10/3

Y1 - 2023/10/3

UR - http://www.scopus.com/inward/record.url?scp=85173638822&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000207861

DO - 10.1212/WNL.0000000000207861

M3 - Editorial

C2 - 37643886

AN - SCOPUS:85173638822

SN - 0028-3878

VL - 101

SP - 593

EP - 594

JO - Neurology

JF - Neurology

IS - 14

ER -